108 related articles for article (PubMed ID: 398600)
21. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.
Cheng H; Tumpey TM; Staats HF; van Rooijen N; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1402-9. PubMed ID: 10798656
[TBL] [Abstract][Full Text] [Related]
22. Histological and electron microscopic studies of experimental herpetic keratitis in the rabbit.
Metcalf JF; Reichert RW
Invest Ophthalmol Vis Sci; 1979 Nov; 18(11):1123-38. PubMed ID: 511456
[TBL] [Abstract][Full Text] [Related]
23. Herpes simplex keratitis.
Kaye S; Choudhary A
Prog Retin Eye Res; 2006 Jul; 25(4):355-80. PubMed ID: 16807055
[TBL] [Abstract][Full Text] [Related]
24. Experimental ulcerative herpetic keratitis. I. Systemic immune responses and resistance to corneal infection.
Carter C; Easty DL
Br J Ophthalmol; 1981 Feb; 65(2):77-81. PubMed ID: 6257272
[TBL] [Abstract][Full Text] [Related]
25. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas.
Hendricks RL; Janowicz M; Tumpey TM
J Immunol; 1992 Apr; 148(8):2522-9. PubMed ID: 1313845
[TBL] [Abstract][Full Text] [Related]
26. Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence.
Grau DR; Visalli RJ; Brandt CR
Invest Ophthalmol Vis Sci; 1989 Dec; 30(12):2474-80. PubMed ID: 2556353
[TBL] [Abstract][Full Text] [Related]
27. Herpes simplex keratitis and keratoconus in the atopic patient. A clinical and immunological study.
Easty D; Entwistle C; Funk A; Witcher J
Trans Ophthalmol Soc U K (1962); 1975 Jul; 95(2):267-76. PubMed ID: 775699
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits.
Nesburn AB; Burke RL; Ghiasi H; Slanina SM; Wechsler SL
Virology; 1998 Dec; 252(1):200-9. PubMed ID: 9875329
[TBL] [Abstract][Full Text] [Related]
29. Alterations in the antigenic structure of two major HSV-1 glycoproteins, gC and gB, influence immune regulation and susceptibility to murine herpes keratitis.
Hendricks RL; Tao MS; Glorioso JC
J Immunol; 1989 Jan; 142(1):263-9. PubMed ID: 2909617
[TBL] [Abstract][Full Text] [Related]
30. Herpes simplex virus glycoprotein D. Protective immunity against murine herpetic keratitis.
Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S
Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):411-8. PubMed ID: 2318582
[TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus--induced destructive corneal disease.
Foster CS
Eye (Lond); 1989; 3 ( Pt 2)():194-203. PubMed ID: 2559859
[No Abstract] [Full Text] [Related]
32. The effect of nonspecific immune stimulation on the recurrence rate of herpetic keratitis in rabbits.
Mudd S; Varnell ED; Engelstein J
Invest Ophthalmol; 1975 Jun; 14(6):469-71. PubMed ID: 166051
[TBL] [Abstract][Full Text] [Related]
33. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
[TBL] [Abstract][Full Text] [Related]
34. The severity of herpes simplex viral keratitis in mice does not reflect the severity of disease in humans.
Rinne JR; Abghari SZ; Stulting RD
Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):268-72. PubMed ID: 1310955
[TBL] [Abstract][Full Text] [Related]
35. A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice.
Miller JK; Laycock KA; Umphress JA; Hook KK; Stuart PM; Pepose JS
Cornea; 1996 Sep; 15(5):497-504. PubMed ID: 8862927
[TBL] [Abstract][Full Text] [Related]
36. Immunology of herpesvirus infection: immunity to herpes simplex virus in eye infections.
Meyers RL; Chitjian PA
Surv Ophthalmol; 1976; 21(2):194-204. PubMed ID: 185741
[TBL] [Abstract][Full Text] [Related]
37. [Role of cell-mediated immunity in the resistance of rabbits to corneal herpes simplex virus infection (author's transl)].
Sasaki T; Gotoh E; Kamata K; Ishikawa R; Dokoh R
Nippon Ganka Gakkai Zasshi; 1977 Sep; 81(9):1268-73. PubMed ID: 605860
[No Abstract] [Full Text] [Related]
38. Diagnosis and management of herpes simplex stromal keratitis.
Wilhelmus KR
Cornea; 1987; 6(4):286-91. PubMed ID: 3319411
[TBL] [Abstract][Full Text] [Related]
39. Corticosteroids in the management of herpetic eye disease.
Williams HP; Falcon MG; Jones BR
Trans Ophthalmol Soc U K (1962); 1977 Jul; 97(2):341-4. PubMed ID: 273345
[TBL] [Abstract][Full Text] [Related]
40. [Immunological study of experimental herpetic keratitis in rabbit - cellular and humoral immunity after re-infection herpes simplex virus (author's transl)].
Dokoh R
Nippon Ganka Gakkai Zasshi; 1981 Aug; 85(8):1094-103. PubMed ID: 7315637
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
